Cargando…
A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
The serotonin receptor 5-HT(1B) is widely expressed in the central nervous system and has been considered a drug target in a variety of cognitive and psychiatric disorders. The anti-inflammatory effects of 5-HT(1B) agonists may present a promising approach for Alzheimer’s disease (AD) treatment. Her...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450432/ https://www.ncbi.nlm.nih.gov/pubmed/34552493 http://dx.doi.org/10.3389/fphar.2021.735876 |
_version_ | 1784569645897875456 |
---|---|
author | Yang, Yang Zhang, Lijing Yu, Jiaojiao Ma, Zhaobin Li, Moxiang Wang, Jin Hu, Pengcheng Zou, Jia Liu, Xueying Liu, Ying An, Su Xiang, Cheng Guo, Xiaoxi Hao, Qian Xu, Tian-Rui |
author_facet | Yang, Yang Zhang, Lijing Yu, Jiaojiao Ma, Zhaobin Li, Moxiang Wang, Jin Hu, Pengcheng Zou, Jia Liu, Xueying Liu, Ying An, Su Xiang, Cheng Guo, Xiaoxi Hao, Qian Xu, Tian-Rui |
author_sort | Yang, Yang |
collection | PubMed |
description | The serotonin receptor 5-HT(1B) is widely expressed in the central nervous system and has been considered a drug target in a variety of cognitive and psychiatric disorders. The anti-inflammatory effects of 5-HT(1B) agonists may present a promising approach for Alzheimer’s disease (AD) treatment. Herbal antidepressants used in the treatment of AD have shown functional overlap between the active compounds and 5-HT(1B) receptor stimulation. Therefore, compounds in these medicinal plants that target and stimulate 5-HT(1B) deserve careful study. Molecular docking, drug affinity responsive target stability, cellular thermal shift assay, fluorescence resonance energy transfer (FRET), and extracellular regulated protein kinases (ERK) 1/2 phosphorylation tests were used to identify emodin-8-O-β-d-glucopyranoside (EG), a compound from Chinese medicinal plants with cognitive deficit attenuating and antidepressant effects, as an agonist of 5-HT(1B). EG selectively targeted 5-HT(1B) and activated the 5-HT(1B)-induced signaling pathway. The activated 5-HT(1B) pathway suppressed tumor necrosis factor (TNF)-α levels, thereby protecting neural cells against beta-amyloid (Aβ)-induced death. Moreover, the agonist activity of EG towards 5-HT(1B) receptor, in FRET and ERK1/2 phosphorylation, was antagonized by SB 224289, a 5-HT(1B) antagonist. In addition, EG relieved AD symptoms in transgenic worm models. These results suggested that 5-HT(1B) receptor activation by EG positively affected Aβ-related inflammatory process regulation and neural death resistance, which were reversed by antagonist SB 224289. The active compounds such as EG might act as potential therapeutic agents through targeting and stimulating 5-HT(1B) receptor for AD and other serotonin-related disorders. This study describes methods for identification of 5-HT(1B) agonists from herbal compounds and for evaluating agonists with biological functions, providing preliminary information on medicinal herbal pharmacology. |
format | Online Article Text |
id | pubmed-8450432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84504322021-09-21 A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease Yang, Yang Zhang, Lijing Yu, Jiaojiao Ma, Zhaobin Li, Moxiang Wang, Jin Hu, Pengcheng Zou, Jia Liu, Xueying Liu, Ying An, Su Xiang, Cheng Guo, Xiaoxi Hao, Qian Xu, Tian-Rui Front Pharmacol Pharmacology The serotonin receptor 5-HT(1B) is widely expressed in the central nervous system and has been considered a drug target in a variety of cognitive and psychiatric disorders. The anti-inflammatory effects of 5-HT(1B) agonists may present a promising approach for Alzheimer’s disease (AD) treatment. Herbal antidepressants used in the treatment of AD have shown functional overlap between the active compounds and 5-HT(1B) receptor stimulation. Therefore, compounds in these medicinal plants that target and stimulate 5-HT(1B) deserve careful study. Molecular docking, drug affinity responsive target stability, cellular thermal shift assay, fluorescence resonance energy transfer (FRET), and extracellular regulated protein kinases (ERK) 1/2 phosphorylation tests were used to identify emodin-8-O-β-d-glucopyranoside (EG), a compound from Chinese medicinal plants with cognitive deficit attenuating and antidepressant effects, as an agonist of 5-HT(1B). EG selectively targeted 5-HT(1B) and activated the 5-HT(1B)-induced signaling pathway. The activated 5-HT(1B) pathway suppressed tumor necrosis factor (TNF)-α levels, thereby protecting neural cells against beta-amyloid (Aβ)-induced death. Moreover, the agonist activity of EG towards 5-HT(1B) receptor, in FRET and ERK1/2 phosphorylation, was antagonized by SB 224289, a 5-HT(1B) antagonist. In addition, EG relieved AD symptoms in transgenic worm models. These results suggested that 5-HT(1B) receptor activation by EG positively affected Aβ-related inflammatory process regulation and neural death resistance, which were reversed by antagonist SB 224289. The active compounds such as EG might act as potential therapeutic agents through targeting and stimulating 5-HT(1B) receptor for AD and other serotonin-related disorders. This study describes methods for identification of 5-HT(1B) agonists from herbal compounds and for evaluating agonists with biological functions, providing preliminary information on medicinal herbal pharmacology. Frontiers Media S.A. 2021-09-06 /pmc/articles/PMC8450432/ /pubmed/34552493 http://dx.doi.org/10.3389/fphar.2021.735876 Text en Copyright © 2021 Yang, Zhang, Yu, Ma, Li, Wang, Hu, Zou, Liu, Liu, An, Xiang, Guo, Hao and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yang, Yang Zhang, Lijing Yu, Jiaojiao Ma, Zhaobin Li, Moxiang Wang, Jin Hu, Pengcheng Zou, Jia Liu, Xueying Liu, Ying An, Su Xiang, Cheng Guo, Xiaoxi Hao, Qian Xu, Tian-Rui A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease |
title | A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease |
title_full | A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease |
title_fullStr | A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease |
title_full_unstemmed | A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease |
title_short | A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease |
title_sort | novel 5-ht(1b) receptor agonist of herbal compounds and one of the therapeutic uses for alzheimer’s disease |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450432/ https://www.ncbi.nlm.nih.gov/pubmed/34552493 http://dx.doi.org/10.3389/fphar.2021.735876 |
work_keys_str_mv | AT yangyang anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT zhanglijing anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT yujiaojiao anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT mazhaobin anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT limoxiang anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT wangjin anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT hupengcheng anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT zoujia anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT liuxueying anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT liuying anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT ansu anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT xiangcheng anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT guoxiaoxi anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT haoqian anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT xutianrui anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT yangyang novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT zhanglijing novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT yujiaojiao novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT mazhaobin novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT limoxiang novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT wangjin novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT hupengcheng novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT zoujia novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT liuxueying novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT liuying novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT ansu novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT xiangcheng novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT guoxiaoxi novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT haoqian novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease AT xutianrui novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease |